Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients

被引：0
|
作者：
Flavia Mattioli
F. Bellomi
C. Stampatori
S. Mariotto
S. Ferrari
S. Monaco
C. Mancinelli
R. Capra
机构：
[1] ASST Spedali Civili,Neuropsychology Unit
[2] University of Verona,Department of Neuroscience, Biomedicine and Movement Sciences
[3] ASST Spedali Civili,MS Center
来源：
Journal of Neurology | 2020年 / 267卷
关键词：
Neurofilaments; Multiple sclerosis; Cognitive impairment; Longitudinal;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2245 / 2251
页数：6
相关论文
共 50 条
  • [41] In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting
    Malucchi, Simona
    Bava, Cecilia Irene
    Valentino, Paola
    Martire, Serena
    Re, Marianna Lo
    Bertolotto, Antonio
    Di Sapio, Alessia
    JOURNAL OF NEUROLOGY, 2024, 271 (12) : 7494 - 7501
  • [42] Serum neurofilament light chain identifies multiple sclerosis patients with severe focal axonal damage in a 6-year longitudinal cohort
    Steffen, F.
    Uphaus, T.
    Fleischer, V.
    Schraad, M.
    Groppa, S.
    Zipp, F.
    Bittner, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 588 - 588
  • [43] Neurofilament light chain levels in blood are predictive of cognitive impairment in patients with secondary progressive multiple sclerosis
    Kuhle, J.
    Kropshofer, H.
    Barro, C.
    Meinert, R.
    Haring, D.
    Leppert, D.
    Dahlke, F.
    Tomic, D.
    Kappos, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 666 - 666
  • [44] The role of Serum Neurofilament Light Chain (NfL) and Glial Fribrillary Acidic Protein (GFAP) in predicting cognitive impairment in patients with Multiple Sclerosis
    Santos, Irina
    Duarte, Leonor
    Machado, Rita Brito
    Fernandes, Catarina
    Correia, Ines
    Macario, Maria do Carmo
    Nunes, Carla
    Jacinto Santana, Maria Isabel
    Baldeiras, Ines
    Batista, Sonia
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 162 - 162
  • [45] Serum neurofilament light chain as a predictor of response in a multicentric cohort of multiple sclerosis patients treated with Ocrelizumab
    Rodriguez Jorge, Fernando
    Fernandez Velasco, Jose Ignacio
    Villarrubia, Noelia
    Gracia-Gil, Julia
    Fernandez Diaz, Eva
    Bau Vila, Laura
    Martinez Yelamos, Sergio
    Diaz Perez, Carolina
    Meca, Virginia
    Sainz De la Maza, Susana
    Pacheco Cortegana, Eva Maria
    Monreal, Enric
    Borrega Canelo, Laura
    Chico Garcia, Juan Luis
    Lopez Real, Ana Maria
    Sainz, Raquel
    Barrero Hernandez, Francisco Javier
    Martinez-Gines, Maria Isabel
    De la Fuente, Soraya
    Moreno Torres, Irene
    Caminero Rodriguez, Ana Belen
    Castellanos Pinedo, Fernando
    Ayuso, Lucia
    Abreu, Rossana
    Meca Lallana, Jose
    Quiroga-Varela, Ana
    Ramio I Torrenta, Lluis
    Masjuan, Jaime
    Costa-Frossard, Lucienne
    Villar Guimerans, Luisa Maria
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 642 - 643
  • [46] Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis
    Fox, Robert J.
    Cree, Bruce A. C.
    de Seze, Jerome
    Gold, Ralf
    Hartung, Hans-Peter
    Jeffery, Douglas
    Kappos, Ludwig
    Montalban, Xavier
    Weinstock-Guttman, Bianca
    Singh, Carol M.
    Altincatal, Arman
    Belviso, Nicholas
    Avila, Robin L.
    Ho, Pei-Ran
    Su, Ray
    Engle, Robert
    Sangurdekar, Dipen
    de Moor, Carl
    Fisher, Elizabeth
    Kieseier, Bernd C.
    Rudick, Richard A.
    NEUROLOGY, 2024, 102 (09) : e209357
  • [47] Neurofilament light chain level in paired CSF and serum samples of patients with multiple sclerosis: a prospective study
    Zanoni, M.
    Bongianni, M.
    Mariotto, S.
    Orlandi, R.
    Calabrese, M.
    Gobbin, F.
    Gajofatto, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 214 - 214
  • [48] Dimethyl fumarate decreases serum neurofilament light chain in relapsing-remitting multiple sclerosis patients
    Sainz De La Maza, S.
    Walo Delgado, P. E.
    Villarrubia, N.
    Monreal, E.
    Espino, M.
    Fernandez-Velasco, J. I.
    Masjuan, J.
    Costa-Frossard, L.
    Villar, L. M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 149 - 150
  • [49] Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels
    Quintanilla-Bordas, Carlos
    Cubas-Nunez, Laura
    Castillo-Villalba, Jessica
    Carratala-Bosca, Sara
    Gasque-Rubio, Raquel
    Tortosa-Carreres, Jordi
    Alcala, Carmen
    Fores-Toribio, Lorena
    Lucas, Celia
    Gorriz, David
    Perez-Miralles, Francisco
    Casanova, Bonaventura
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [50] Anti-MOG antibodies and neurofilament light chain serum levels in tumefactive multiple sclerosis: a longitudinal case report
    Breza, M.
    Tzartos, J. S.
    Koutsis, G.
    Tzanetakos, D.
    Evangelopoulos, M. E.
    Karagiorgou, K.
    Andreadou, E.
    Anagnostouli, M.
    Kilidireas, C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 810 - 810
12345